Image showing a doctor performing clinical trial

Proactive Study Start-Up Support: Tailored Strategies for Small and Mid-Sized Sponsors Every clinical supply project comes with its own set of risks, owing to the inherent uniqueness of each study. The complexity of a project can often be traced back to specific characteristics present in the protocol design, study scope, drug properties, and sponsor resources. Addressing these potential challenges demands a holistic and integrated approach during the study start-up phase, along with proactive strategies to avert any issues that may arise. To achieve this, Clinical Supply Management (CSM) takes the helm, serving as the first line of defense in devising a robust execution plan.


author avatar
Sridhar Gumudavelli
Sridhar Gumudavelli serves as the Vice President of Formulation R&D at Renejix Pharma Solutions, where he brings a wealth of knowledge and experience to the table. His leadership is instrumental in navigating the complex process of drug formulation, leveraging a variety of technologies to enhance drug absorption, bioavailability, and patient compliance.Sridhar’s expertise is not just limited to his hands-on experience; he is also an innovator with several patents filed under his name. These patents reflect his contributions to advancing drug delivery systems, showcasing his ability to tackle some of the most challenging problems in pharmaceutical sciences for the past 30+ years.

Similar Posts